Vysis 07J22-050
Ref 07J22-050
Vysis 07J22-050 is a cancer/tumour-associated aneuploidy IVD (EU IVDD general IVD; FDA Class I) made by Abbott Molecular, registered in EUDAMED on 5 Nov 2026 (Basic UDI-DI B-00884999027091), cleared under FDA 510(k) K954214 on 21 Jan 1997 and listed in FDA GUDID since 10 Sep 2016 (UDI-DI 00884999027091), active as of 7 Nov 2026.
Active
CE IVDD 510(k)
Valid until
No date given
FDA recalls
None found
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/IVDD EUDAMED | NumberB-00884999027091 00884999027091 | Date5 Nov 2026 | StatusActive |
| United States | GUDID listing GUDID | Number00884999027091 | Date10 Sep 2016 | StatusListed |
| United States | FDA 510(k)SESE GUDID | NumberK954214 | Date21 Jan 1997 | StatusActive |
Official records
- EUDAMED public site B-00884999027091
- AccessGUDID record 00884999027091
- FDA 510(k) database K954214
From the FDA record
- Device description
- Vysis CEP X SpectrumOrange/ Y SpectrumGreen
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- EUDAMED Basic UDI-DI B-00884999027091 registered 5 Nov 2026 Active
- FDA 510(k) K954214 decided 21 Jan 1997 Active
- FDA GUDID UDI-DI 00884999027091 listed 10 Sep 2016 Listed
Certificates
No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.
Timeline
- Cleared FDA 510(k) K954214
- Listed FDA GUDID 00884999027091
- Registered EUDAMED B-00884999027091
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- Trade name
- Vysis
- Generic name
- Cancer/tumour-associated aneuploidy IVD, probe
- Model / Ref / Catalog
- 07J22-050
- Primary DI / UDI-DI
- 00884999027091
- Basic UDI-DI
- B-00884999027091
- 510(k) Number
- FDA product code
- KIR, OXP
- EMDN code
- W01060299 Tests for acquired genetic or chromosomal alterations - other
- GMDN term
- Cancer/tumour-associated aneuploidy IVD, probe
- Device class
- Class IVD General EUDAMEDClass I GUDID
- Regulation number
- 864.2280, 866.6010
- EU registration type
- Legacy device (under a directive)
- EU market of registration
- Germany
- GUDID distribution status
- In Commercial Distribution
Truth per registry
| Field | EUDAMED | GUDID |
|---|---|---|
| Device class | Class IVD General | Class I |
Similar devices in this category
Other devices filed under TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER.
- AML1/ETO (RUNX1/RUNX1T1) Translocation, Dual Fusion Probe CE-LPH 026 by Cytocell, Ltd.
- Human EGFR, KRAS, BRAF, NRAS, PIK3CA Gene Mutation Joint Detection Kit (Combinatorial Probe Anchor Synthesis) USCI-JK001 by Beijing USCI Medical Devices Co., Ltd.
- Del(20q) Deletion Probe CE-LPH 020 by Cytocell, Ltd.
- LeukoStrat CDx FLT3 Mutation Assay K4120431 by Invivoscribe, Inc.
- Oncomine™ Dx Target RNA Control Kit A32443 (A49756) by LIFE TECHNOLOGIES LIMITED
- Fast Fluorescence In Situ Hybridization Probe Kit FP-006 by Wuhan HealthCare Biotechnology Co., Ltd.
- GynTect GT003-10 by Epitype GmbH
- Human B Lymphocyte Minimal Residual Disease Detection Kit RSN040 by Genetron Health (Beijing) Co., Ltd.
- Diagnostic Kit for Methylated Genes of Breast Cancer(Real Time PCR) BRC-PCR-30-CE by Excellen Medical Technology Co., Ltd.
- TruSight™ Oncology Comprehensive (DRAGEN) 20140799 by Illumina, Inc.